                         SEQUENCE LISTING

<110>  Ortigosa, Allison D
       Chmielowski, Rebecca A
       Sleevi, Mark C
 
<120>  A PROCESS FOR OBTAINING INSULIN WITH CORRECTLY FORMED DISULFIDE 
       BONDS

<130>  24167

<150>  62/131,159
<151>  2015-09-02

<160>  6     

<170>  PatentIn version 3.5

<210>  1
<211>  21
<212>  PRT
<213>  Homo sapiens

<400>  1

Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu 
1               5                   10                  15      


Glu Asn Tyr Cys Asn 
            20      


<210>  2
<211>  30
<212>  PRT
<213>  Homo sapiens

<400>  2

Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr 
1               5                   10                  15      


Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr 
            20                  25                  30  


<210>  3
<211>  102
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Precursor insulin glargine

<400>  3

Ser Gln Ser Ile Gly Val Phe Val Gln Asp Tyr Asn Ser His Thr Arg 
1               5                   10                  15      


Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr 
            20                  25                  30          


Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr Arg Arg 
        35                  40                  45              


Glu Ala Glu Asp Leu Gln Val Gly Gln Val Glu Leu Gly Gly Gly Pro 
    50                  55                  60                  


Gly Ala Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys 
65                  70                  75                  80  


Arg Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln 
                85                  90                  95      


Leu Glu Asn Tyr Cys Gly 
            100         


<210>  4
<211>  102
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Precursor insulin lispro

<400>  4

Ser Gln Ser Ile Gly Val Phe Val Gln Asp Tyr Asn Ser His Thr Arg 
1               5                   10                  15      


Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr 
            20                  25                  30          


Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Lys Pro Thr Arg Arg 
        35                  40                  45              


Glu Ala Glu Asp Leu Gln Val Gly Gln Val Glu Leu Gly Gly Gly Pro 
    50                  55                  60                  


Gly Ala Gly Ser Leu Gln Pro Leu Ala Leu Glu Gly Ser Leu Gln Lys 
65                  70                  75                  80  


Arg Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln 
                85                  90                  95      


Leu Glu Asn Tyr Cys Asn 
            100         


<210>  5
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Insulin glargine A chain

<400>  5

Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu 
1               5                   10                  15      


Glu Asn Tyr Cys Gly 
            20      


<210>  6
<211>  32
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Insulin glargine B chain

<400>  6

Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr 
1               5                   10                  15      


Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr Arg Arg 
            20                  25                  30          


